Cargando…
Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study
BACKGROUND: Management of epilepsy during pregnancy in a resource-limited setting (RLS) is challenging. This study aimed to assess obstetric outcomes and effects on babies of women with epilepsy (WWE) exposed to Anti-epileptic drugs (AEDs) compared to non-exposed controls in a RLS. METHODS: Pregnant...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000926/ https://www.ncbi.nlm.nih.gov/pubmed/29898689 http://dx.doi.org/10.1186/s12884-018-1857-3 |
_version_ | 1783331865089802240 |
---|---|
author | Galappatthy, Priyadarshani Liyanage, Chiranthi Kongala Lucas, Marianne Nishani Jayasekara, Dilini T. L. M. Abhayaratna, Sachith Aloka Weeraratne, Chamari De Abrew, Kusum Gunaratne, Padma Sriyani Gamage, Ranjani Wijeyaratne, Chandrika N. |
author_facet | Galappatthy, Priyadarshani Liyanage, Chiranthi Kongala Lucas, Marianne Nishani Jayasekara, Dilini T. L. M. Abhayaratna, Sachith Aloka Weeraratne, Chamari De Abrew, Kusum Gunaratne, Padma Sriyani Gamage, Ranjani Wijeyaratne, Chandrika N. |
author_sort | Galappatthy, Priyadarshani |
collection | PubMed |
description | BACKGROUND: Management of epilepsy during pregnancy in a resource-limited setting (RLS) is challenging. This study aimed to assess obstetric outcomes and effects on babies of women with epilepsy (WWE) exposed to Anti-epileptic drugs (AEDs) compared to non-exposed controls in a RLS. METHODS: Pregnant WWE were recruited from antenatal and neurology clinics of a tertiary care hospitals in Sri Lanka. Patients were reviewed in each trimester and post-partum. Medication adherence, adverse effects, seizure control and carbamazepine blood levels were monitored. Post-partum, measurements for anthropometric and dysmorphic features of the babies and congenital abnormalities were recorded. Age and sex matched babies not exposed to AED recruited as controls were also examined. RESULTS: Ninety-six pregnant WWE were recruited (mean period of gestation 22.9 weeks). Mean age was 28 years and 48(50%) were primigravidae. Fifty percent (48) were on monotherapy, while 23.8, 15.9 and 4.1% were on two, three and four AEDs respectively. AEDs in first trimester (TM1) were carbamazepine (71%), valproate (25.8%) clobazam (29.5%), lamotrigine (7%) topiramate (5%) and others (3.4%). Sodium valproate use reduced significantly from T1 to T2(p < 0.05). Sub-therapeutic carbamazepine levels correlated positively (r = 0.547) with poor medication adherence (p = 0.009) and negatively (r = 0.306) with adverse effects (p = 0.002). Seventy-six WWE completed follow-up reporting w 75 (98.6%) live births and one T1 miscarriage (1.3%). Three (4.3%) were preterm. Majority (73.33%) were normal vaginal deliveries. Cesarean sections were not increased in WWE. Fifty-nine (61.45%) babies were examined. For those examined during infancy, 53 age and sex matched controls were recruited and examined.. Congenital abnormalities occurred in 5 (9.43%) babies of WWE [atrio-ventricular septal defect (2), renal hypoplasia (1), cryptorchidism (1), microcephaly (1)] compared to 2 (3.77%) in controls (2 microcephaly; p = 0.24). Fetal exposure to AEDs increased a risk of low birth weight (RR 2.8; p = 0.049). Anthropometric parameters of AED exposed babies were lower at birth but not statistically significant between the two groups (weight p = 0.263, length p = 0.363, occipito-frontal circumference (OFC) p = 0.307). However, weight (p = 0.009), length (p = 0.016) and OFC (p = 0.002) were significantly lower compared to controls at an average of 3.52 months. CONCLUSION: Most pregnancies are unplanned in the RLS studied, and AEDs were altered during pregnancy. Congenital anomalies occurred at rates comparable to previous reports. Fetal exposure to AED had growth retardation in infancy compared to non-exposed babies. |
format | Online Article Text |
id | pubmed-6000926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60009262018-06-25 Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study Galappatthy, Priyadarshani Liyanage, Chiranthi Kongala Lucas, Marianne Nishani Jayasekara, Dilini T. L. M. Abhayaratna, Sachith Aloka Weeraratne, Chamari De Abrew, Kusum Gunaratne, Padma Sriyani Gamage, Ranjani Wijeyaratne, Chandrika N. BMC Pregnancy Childbirth Research Article BACKGROUND: Management of epilepsy during pregnancy in a resource-limited setting (RLS) is challenging. This study aimed to assess obstetric outcomes and effects on babies of women with epilepsy (WWE) exposed to Anti-epileptic drugs (AEDs) compared to non-exposed controls in a RLS. METHODS: Pregnant WWE were recruited from antenatal and neurology clinics of a tertiary care hospitals in Sri Lanka. Patients were reviewed in each trimester and post-partum. Medication adherence, adverse effects, seizure control and carbamazepine blood levels were monitored. Post-partum, measurements for anthropometric and dysmorphic features of the babies and congenital abnormalities were recorded. Age and sex matched babies not exposed to AED recruited as controls were also examined. RESULTS: Ninety-six pregnant WWE were recruited (mean period of gestation 22.9 weeks). Mean age was 28 years and 48(50%) were primigravidae. Fifty percent (48) were on monotherapy, while 23.8, 15.9 and 4.1% were on two, three and four AEDs respectively. AEDs in first trimester (TM1) were carbamazepine (71%), valproate (25.8%) clobazam (29.5%), lamotrigine (7%) topiramate (5%) and others (3.4%). Sodium valproate use reduced significantly from T1 to T2(p < 0.05). Sub-therapeutic carbamazepine levels correlated positively (r = 0.547) with poor medication adherence (p = 0.009) and negatively (r = 0.306) with adverse effects (p = 0.002). Seventy-six WWE completed follow-up reporting w 75 (98.6%) live births and one T1 miscarriage (1.3%). Three (4.3%) were preterm. Majority (73.33%) were normal vaginal deliveries. Cesarean sections were not increased in WWE. Fifty-nine (61.45%) babies were examined. For those examined during infancy, 53 age and sex matched controls were recruited and examined.. Congenital abnormalities occurred in 5 (9.43%) babies of WWE [atrio-ventricular septal defect (2), renal hypoplasia (1), cryptorchidism (1), microcephaly (1)] compared to 2 (3.77%) in controls (2 microcephaly; p = 0.24). Fetal exposure to AEDs increased a risk of low birth weight (RR 2.8; p = 0.049). Anthropometric parameters of AED exposed babies were lower at birth but not statistically significant between the two groups (weight p = 0.263, length p = 0.363, occipito-frontal circumference (OFC) p = 0.307). However, weight (p = 0.009), length (p = 0.016) and OFC (p = 0.002) were significantly lower compared to controls at an average of 3.52 months. CONCLUSION: Most pregnancies are unplanned in the RLS studied, and AEDs were altered during pregnancy. Congenital anomalies occurred at rates comparable to previous reports. Fetal exposure to AED had growth retardation in infancy compared to non-exposed babies. BioMed Central 2018-06-14 /pmc/articles/PMC6000926/ /pubmed/29898689 http://dx.doi.org/10.1186/s12884-018-1857-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Galappatthy, Priyadarshani Liyanage, Chiranthi Kongala Lucas, Marianne Nishani Jayasekara, Dilini T. L. M. Abhayaratna, Sachith Aloka Weeraratne, Chamari De Abrew, Kusum Gunaratne, Padma Sriyani Gamage, Ranjani Wijeyaratne, Chandrika N. Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study |
title | Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study |
title_full | Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study |
title_fullStr | Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study |
title_full_unstemmed | Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study |
title_short | Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study |
title_sort | obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000926/ https://www.ncbi.nlm.nih.gov/pubmed/29898689 http://dx.doi.org/10.1186/s12884-018-1857-3 |
work_keys_str_mv | AT galappatthypriyadarshani obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy AT liyanagechiranthikongala obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy AT lucasmariannenishani obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy AT jayasekaradilinitlm obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy AT abhayaratnasachithaloka obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy AT weeraratnechamari obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy AT deabrewkusum obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy AT gunaratnepadmasriyani obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy AT gamageranjani obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy AT wijeyaratnechandrikan obstetricoutcomesandeffectsonbabiesborntowomentreatedforepilepsyduringpregnancyinaresourcelimitedsettingacomparativecohortstudy |